Free Trial

Ontrak (OTRK) Competitors

Ontrak logo
$1.46 +0.01 (+0.34%)
As of 01:19 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

OTRK vs. MRAI, ENZ, BRTX, MGRX, SSY, BGLC, ACON, VSEE, DHAC, and ATIP

Should you be buying Ontrak stock or one of its competitors? The main competitors of Ontrak include Marpai (MRAI), Enzo Biochem (ENZ), BioRestorative Therapies (BRTX), Mangoceuticals (MGRX), SunLink Health Systems (SSY), BioNexus Gene Lab (BGLC), Aclarion (ACON), Vsee Health (VSEE), Digital Health Acquisition (DHAC), and ATI Physical Therapy (ATIP). These companies are all part of the "healthcare" industry.

Ontrak vs. Its Competitors

Ontrak (NASDAQ:OTRK) and Marpai (NASDAQ:MRAI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, community ranking, risk, valuation, analyst recommendations, profitability, institutional ownership and media sentiment.

Ontrak has a beta of 2.38, meaning that its share price is 138% more volatile than the S&P 500. Comparatively, Marpai has a beta of 4.8, meaning that its share price is 380% more volatile than the S&P 500.

Ontrak received 36 more outperform votes than Marpai when rated by MarketBeat users. However, 66.67% of users gave Marpai an outperform vote while only 59.38% of users gave Ontrak an outperform vote.

CompanyUnderperformOutperform
OntrakOutperform Votes
38
59.38%
Underperform Votes
26
40.63%
MarpaiOutperform Votes
2
66.67%
Underperform Votes
1
33.33%

Ontrak has higher earnings, but lower revenue than Marpai. Marpai is trading at a lower price-to-earnings ratio than Ontrak, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ontrak$10.18M0.61-$27.92M-$15.81-0.09
Marpai$34.87M0.63-$28.75M-$1.82-0.76

Ontrak currently has a consensus price target of $45.00, suggesting a potential upside of 2,971.67%. Given Ontrak's stronger consensus rating and higher probable upside, equities research analysts plainly believe Ontrak is more favorable than Marpai.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ontrak
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Marpai
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Ontrak had 2 more articles in the media than Marpai. MarketBeat recorded 2 mentions for Ontrak and 0 mentions for Marpai. Ontrak's average media sentiment score of 0.93 beat Marpai's score of 0.00 indicating that Ontrak is being referred to more favorably in the media.

Company Overall Sentiment
Ontrak Positive
Marpai Neutral

12.9% of Ontrak shares are held by institutional investors. Comparatively, 49.8% of Marpai shares are held by institutional investors. 1.9% of Ontrak shares are held by company insiders. Comparatively, 61.3% of Marpai shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Marpai has a net margin of -85.70% compared to Ontrak's net margin of -237.77%. Marpai's return on equity of 0.00% beat Ontrak's return on equity.

Company Net Margins Return on Equity Return on Assets
Ontrak-237.77% -171.34% -113.42%
Marpai -85.70%N/A -100.23%

Summary

Marpai beats Ontrak on 10 of the 18 factors compared between the two stocks.

Get Ontrak News Delivered to You Automatically

Sign up to receive the latest news and ratings for OTRK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OTRK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OTRK vs. The Competition

MetricOntrakhealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ Exchange
Market Cap$6.18M$2.00B$5.61B$8.57B
Dividend YieldN/A7.21%5.28%4.17%
P/E Ratio-0.1416.0227.2219.81
Price / Sales0.614.15411.31154.51
Price / CashN/A9.3238.3234.64
Price / Book0.263.927.014.65
Net Income-$27.92M$87.49M$3.23B$248.05M
7 Day Performance-4.25%-2.70%-0.06%-0.15%
1 Month Performance-11.75%-1.79%8.75%4.50%
1 Year Performance-56.78%-20.38%32.44%13.76%

Ontrak Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OTRK
Ontrak
2.6201 of 5 stars
$1.47
+0.3%
$45.00
+2,971.7%
-57.9%$6.18M$10.18M-0.14250
MRAI
Marpai
N/A$1.31
-3.7%
N/A+59.3%$20.58M$34.87M-0.50150
ENZ
Enzo Biochem
N/A$0.33
-14.8%
N/A-72.0%$17.03M$29.09M0.00520Gap Down
High Trading Volume
BRTX
BioRestorative Therapies
3.9334 of 5 stars
$1.81
+0.3%
$18.00
+894.5%
+48.1%$13.58M$391K-1.187News Coverage
Gap Down
High Trading Volume
MGRX
Mangoceuticals
0.5209 of 5 stars
$2.05
+0.5%
N/A-97.6%$10.60M$511.08K-0.353Short Interest ↑
Gap Down
SSY
SunLink Health Systems
1.0932 of 5 stars
$1.00
+13.0%
N/A+34.7%$7.01M$31.09M7.111,376Short Interest ↑
BGLC
BioNexus Gene Lab
0.4023 of 5 stars
$3.07
-1.0%
N/A-38.7%$5.52M$9.27M0.0030Gap Up
ACON
Aclarion
2.4816 of 5 stars
$7.13
+3.8%
$11,758.50
+164,815.8%
-99.7%$4.15M$54.60K0.007Short Interest ↓
VSEE
Vsee Health
2.36 of 5 stars
$1.14
+0.1%
$5.00
+338.2%
N/A$4.11M$6.38M0.00N/AGap Up
DHAC
Digital Health Acquisition
N/A$1.14
+0.9%
N/A-92.3%$4.11MN/A0.002,021
ATIP
ATI Physical Therapy
0.2949 of 5 stars
$0.93
-7.3%
N/A-77.0%$4.09M$741.86M-0.055,600Gap Down

Related Companies and Tools


This page (NASDAQ:OTRK) was last updated on 6/13/2025 by MarketBeat.com Staff
From Our Partners